2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Sundeep Khosla, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atenolol for the Prevention of Osteoporosis (APO) Atenolol 50 MG, Placebo - Healthy | Phase 2 | Completed | Sundeep Khosla, M.D. | 420 | 2021-07-27 | 2026-05-05 |
| Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans Dasatinib, Quercetin, Fisetin - Healthy | Phase 2 | Completed | Sundeep Khosla, M.D. | 74 | 2020-06-09 | 2024-07-22 |
Atenolol (1) · Dasatinib (1) · Quercetin (1) · fisetin (1)
United States (2)